Angiotensin receptor blockers (ARBs) reduce the risk of lung cancer: a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Clinical and Experimental Medicine

• Publication date

  2015-08-15

• Fields of study

  Medicine

• Identifiers
  PMID 26550179PMCID PMC4612864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin receptor blockers: are they related to lung cancer?

  2013cited by this paper
• Long-term use of angiotensin II receptor blockers and risk of cancer: a population-based cohort analysis.

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database

  2012cited by this paper
• Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer

  2012cited by this paper
• Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study.

  2012cited by this paper
• Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

  2011cited by this paper
• Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study.

  2011cited by this paper
• Use of Angiotensin Receptor Blockers and the Risk of Cancer

  2011cited by this paper
• Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension.

  2011cited by this paper
• Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.

  2010cited by this paper
• Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

  2009cited by this paper
• Telmisartan to prevent recurrent stroke and cardiovascular events.

  2008cited by this paper
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

  2003cited by this paper
• Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II.

  2002influential reference
• International union of pharmacology. XXIII. The angiotensin II receptors.

  2000cited by this paper
• Angiotensin II elevates cytosolic free calcium in human lung adenocarcinoma cells via activation of AT1 receptors.

  1994cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Unlocking the potential of targeting the angiotensin II type 1 receptor in cancer

  2025cites this paper
• Concentrations of Transition Metal Ions in Rat Lungs after Tobacco Smoke Exposure and Treatment with His-Leu Dipeptide

  2023cites this paper
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as potential therapeutic options for pancreatic cancer.

  2022cites this paper
• Lung cancer risk and the inhibitors of angiotensin converting enzyme; an updated review on recent evidence

  2021cites this paper
• Association between Angiotensin-Converting Enzyme Inhibitors and Lung Cancer—A Nationwide, Population-Based, Propensity Score-Matched Cohort Study

  2020cites this paper
• Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview

  2020cites this paper
• Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions

  2020cites this paper
• Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma

  2020cites this paper
• Risk of lung cancer and renin–angiotensin blockade: a concise review

  2020cites this paper
• Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort

  2020cites this paper
• Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway.

  2018cites this paper
• Novel 18F-Labeled PET Imaging Agent FV45 Targeting the Renin–Angiotensin System

  2018cites this paper
• Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan

  2018cites this paper
• 18F‐Labeled Derivatives of Irbesartan for Angiotensin II Receptor PET Imaging

  2018cites this paper
• COMPARATIVE ANALYSIS OF THE ANTICANCER ACTIVITY OF ANGIOTENSIN RECEPTOR BLOCKERS - IRBESARTAN AND TELMISARTAN

  2018cites this paper
• Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study

  2018cites this paper
• Angiotensin II receptor blockers induce autophagy in prostate cancer cells

  2017cites this paper
• Alterations in Gene Expression of Components of the Renin-Angiotensin System and Its Related Enzymes in Lung Cancer

  2017cites this paper
• Effect of hyperoside on the apoptosis of A549 human non-small cell lung cancer cells and the underlying mechanism

  2017cites this paper